Valuation Scinai Immunotherapeutics Ltd.

Stocks

Delayed Nasdaq Other stock markets 22:11:02 10/08/2026 +04			5-day change	1st Jan Change
0.2474 ^USD	+0.86%		-7.36%	-64.49%

09:53pm	Scinai Biopharma Services Ltd. Wholly Owned Subsidiary of Scinai Immunotherapeutics Ltd. Announces Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration	CI
06-15	Scinai Immunotherapeutics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	32.39	43.42	10.32	2.591	2.853	2.47
Change	-	34.05%	-76.24%	-74.89%	10.12%	-13.44%
Enterprise Value (EV) ¹	90.13	59.12	17.78	18.28	2.975	3.076
Change	-	-34.41%	-69.92%	2.8%	-83.73%	3.38%
P/E	-6.99x	-0.83x	-0.74x	-0.36x	-	-0.2x
PBR	-2.22x	1.9x	-5.52x	-0.61x	0.66x	1x
PEG	-	-0x	0x	0x	-	-
Capitalization / Revenue	-	-	-	-	4,336,274x	1,883,846x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	10.2x	-1.77x	-1.69x	-1.99x	-0.43x	-0.5x
EV / EBIT	12.3x	-1.7x	-1.61x	-1.88x	-0.34x	-0.41x
EV / FCF	-14.9x	-4.18x	-2.07x	-3.1x	-0.78x	-0.92x
FCF Yield	-6.7%	-23.9%	-48.2%	-32.3%	-128%	-108%
Dividend per Share ³	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ³	-40.2	-283.2	-40	-16.64	-	-3.558
Distribution rate	-	-	-	-	-	-
Net sales	-	-	-	-	0.658	1.311
EBITDA ¹	8.84	-33.31	-10.5	-9.192	-6.989	-6.121
EBIT ¹	7.334	-34.83	-11.06	-9.706	-8.638	-7.542
Net income ¹	-4.455	-39.98	-5.796	-6.5	4.796	-8.307
Net Debt ¹	57.74	15.7	7.467	15.69	0.122	0.606
Reference price ³	281.0000	235.0000	29.6000	5.9540	3.3450	0.7121
Nbr of stocks (in thousands)	115	185	349	435	853	3,468
Announcement Date	13/05/21	28/03/22	17/04/23	15/05/24	07/05/25	01/04/26

¹USD in Million²ILS in Million³USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SCINAI IMMUNOTHERAPEUTICS LTD.	-	-	-	-	971K
LONZA GROUP AG	33.6x	6x	17.84x	0.95%	49.47B
REVOLUTION MEDICINES, INC.	-21.68x	304.44x	-21.6x	-.--%	43.97B
BEONE MEDICINES AG	46.07x	5.25x	28.89x	-.--%	39.6B
IQVIA HOLDINGS INC.	30.74x	3.05x	13.16x	-.--%	39.29B
CELLTRION, INC.	30.33x	8.75x	21.99x	0.38%	32.43B
MEDPACE HOLDINGS, INC.	33.59x	5.5x	24.99x	-.--%	16.49B
EUROFINS SCIENTIFIC SE	23.22x	2.04x	8.82x	1.16%	14.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	65.72x	3.81x	14.73x	-.--%	12.77B
Average	30.20x	42.35x	13.60x	0.31%	27.56B
Weighted average by Cap.	25.98x	58.31x	12.22x	0.31%